IDCO: Difference between revisions
m get png image |
beak out a couple of benefits, break up long paragraph in Details to improve readability |
||
| Line 12: | Line 12: | ||
==Benefits== | ==Benefits== | ||
*Standards based translation and transfer of summary device interrogation information | |||
*Improved workflow efficiencies in Cardiology and Electrophysiology practices from management of “key” summary implantable rhythm control device interrogation information in a central system such as an electronic health record system (EHR) or a device clinic management system. | |||
==Details== | |||
Cardiac physicians follow patients with implantable cardiac devices from multiple vendors. | Cardiac physicians follow patients with implantable cardiac devices from multiple vendors. | ||
These devices are categorized as pacemakers, implantable cardioverter defibrillators, cardiac | These devices are categorized as pacemakers, implantable cardioverter defibrillators, cardiac | ||
resynchronization therapy devices, and cardiac monitor devices. As part of patient follow-up an | resynchronization therapy devices, and cardiac monitor devices. | ||
As part of patient follow-up an | |||
interrogation of a cardiac device is performed (either in-clinic or from a remote location). | interrogation of a cardiac device is performed (either in-clinic or from a remote location). | ||
Information is collected about the device such as device identification, therapy settings, device | Information is collected about the device such as device identification, therapy settings, device | ||
diagnostics, and device testing. These interrogations are performed by vendor proprietary | diagnostics, and device testing. These interrogations are performed by vendor proprietary | ||
equipment. | equipment. | ||
To improve workflow efficiencies Cardiology and Electrophysiology practices require the | To improve workflow efficiencies Cardiology and Electrophysiology practices require the | ||
management of “key” summary implantable rhythm control device interrogation information in a | management of “key” summary implantable rhythm control device interrogation information in a | ||
| Line 26: | Line 34: | ||
defines a standards based translation and transfer of summary device interrogation information | defines a standards based translation and transfer of summary device interrogation information | ||
from the interrogation system to the information management system. | from the interrogation system to the information management system. | ||
With the increased use of EHR systems, the networking of in-clinic and remote follow-up | With the increased use of EHR systems, the networking of in-clinic and remote follow-up | ||
systems for implanted cardiac devices, and the continued growth of the implantable cardiac | systems for implanted cardiac devices, and the continued growth of the implantable cardiac | ||
| Line 33: | Line 42: | ||
that the use of this profile will be a critical component of comprehensive cardiac care. | that the use of this profile will be a critical component of comprehensive cardiac care. | ||
==Systems Affected== | ==Systems Affected== | ||
Revision as of 10:44, 31 August 2009
Implantable Device - Cardiac - Observations (IDCO) communicates implantable cardiac device data to EMRs and device management systems.
Summary
This Supplement adds a new profile to the IHE Patient Care Device Technical Framework describing a means to transfer information from an interrogated implantable cardiac device to information management systems. This profile is named Implantable Device – Cardiac – Observation or IDCO for short.
Benefits
- Standards based translation and transfer of summary device interrogation information
- Improved workflow efficiencies in Cardiology and Electrophysiology practices from management of “key” summary implantable rhythm control device interrogation information in a central system such as an electronic health record system (EHR) or a device clinic management system.
Details
Cardiac physicians follow patients with implantable cardiac devices from multiple vendors. These devices are categorized as pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy devices, and cardiac monitor devices.
As part of patient follow-up an interrogation of a cardiac device is performed (either in-clinic or from a remote location). Information is collected about the device such as device identification, therapy settings, device diagnostics, and device testing. These interrogations are performed by vendor proprietary equipment.
To improve workflow efficiencies Cardiology and Electrophysiology practices require the management of “key” summary implantable rhythm control device interrogation information in a central system such as an electronic health record system (EHR) or a device clinic management system. To address this requirement, the Implantable Device – Cardiac – Observation (IDCO) Profile defines a standards based translation and transfer of summary device interrogation information from the interrogation system to the information management system.
With the increased use of EHR systems, the networking of in-clinic and remote follow-up systems for implanted cardiac devices, and the continued growth of the implantable cardiac device market, the importance of this profile to clinicians has become more acute. Strong device and EHR vendor participation in the IDCO profile development is an acknowledgement of this importance. As the IDCO Profile and associated standards continue to evolve there is little doubt that the use of this profile will be a critical component of comprehensive cardiac care.
Systems Affected
- EHR systems may store, manage, and/or display IDCO reports.
Actors & Transactions:
Specification
Profile Status: Trial Implementation
Documents:
Underlying Standards:
This page is based on the Profile Overview Template